SciELO - Scientific Electronic Library Online

 
vol.38 número3Estimulación cerebral profunda del globo pálido interno en el síndrome de distonía mioclónica: serie de 3 casos y revisión de la literaturaTétanos generalizado: reporte de caso y análisis clínico para su diferenciación con otras entidades como las crisis epilépticas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Acta Neurológica Colombiana

versión impresa ISSN 0120-8748versión On-line ISSN 2422-4022

Resumen

MORENO VARGAS, Eder A. et al. Cost analysis of in hospital attention in a non-valvular atrial fibrillation patient and recurrent stroke. Acta Neurol Colomb. [online]. 2022, vol.38, n.3, pp.139-147.  Epub 22-Oct-2022. ISSN 0120-8748.  https://doi.org/10.22379/24224022419.

INTRODUCTION:

A 71-year-old patient with a diagnosis of atrial fibrillation and recurrent strokes, treated with various anticoagulants, the stroke treatment in Colombia for 2008 was $ 450 billion Colombian pesos.

OBJECTIVE:

To estimate the hospital cost of caring for a patient with recurrent stroke secondary to atrial fibrillation.

METHODS:

Partial economic study of micro costing of in-hospital care for a case of recurrent severe spectrum stroke, which does not necessarily reflect the average case. Resource consumption was valued using national reference rates. The results are presented in current 2019 prices (Colombian pesos and US dollars).

RESULTS:

Patient with 3 hospital events, who was hospitalized for 31 days. Hospitalizations had costs of $ 53,883,490 (USD 16,141.1), $ 6,343,096 (USD 1,900.1) and $ 15,719,443 (USD 4,708.9) respectively, with an average price for each hospitalization of $ 25,315,343 (USD 7,583.4), total cost of $ 75,946,029 (USD 22,750.1) daily cost of $ 2,449,872 (USD 729.5). The item that consistently increased costs was procedures (35.7 %).

CONCLUSIONS:

Recurrent stroke caused by nonvalvular atrial fibrillation is associated with a significant increase in direct costs, with an impact of almost twice the GDP per capita. A timely diagnosis and proper selection can reduce it.

Palabras clave : Stroke; Atrial fibrillation; Costs and cost analysis; Anticoagulants; Economics, medical (MeSH).

        · resumen en Español     · texto en Español     · Español ( pdf )